1. Identification of Interleukin-13 Receptor α2 Peptide Analogues Capable of Inducing Improved Antiglioma CTL Responses
   Junichi Eguchi et al, 2006, Cancer Research CrossRef
2. Blood–Brain Barrier Modulation to Improve Glioma Drug Delivery
   Huilong Luo et al, 2020, Pharmaceutics CrossRef
3. Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
   Mahmoud S. Alghamri et al, 2021, Frontiers in Pharmacology CrossRef
4. Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted Therapies
   John S. Jarboe et al, 2007, Cancer Research CrossRef
5. Prioritization schema for immunotherapy clinical trials in glioblastoma
   Tiffany R. Hodges et al, 2016, OncoImmunology CrossRef
6. Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment
   Andrea Franson et al, 2022, Frontiers in Medicine CrossRef
7. Genetically Modified Cellular Therapies for Malignant Gliomas
   Michael Kilian et al, 2021, International Journal of Molecular Sciences CrossRef